Prajna N V, Ellwein L B, Selvaraj S, Manjula K, Kupfer C
Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India.
Am J Ophthalmol. 2000 Sep;130(3):304-9. doi: 10.1016/s0002-9394(00)00481-5.
To estimate the cumulative incidence of posterior capsule opacification 4 years after surgery in patients who participated in the Madurai Intraocular Lens Study and had extracapsular cataract extraction with posterior chamber intraocular lens implantation.
In the Madurai Intraocular Lens Study, 1,700 patients with best-corrected visual acuity 20/120 or worse in the better eye had extracapsular cataract extraction with posterior chamber intraocular lens implantation, and 1,474 (86.7%) of these completed the 1-year follow-up examination. From this group of 1,474 pseudophakic patients, 400 were randomly selected for reexamination 4 years after the original surgery. The eye that was operated on was examined by an ophthalmologist who was involved in the 1-year follow-up examinations and posterior capsule opacification grading. A grading of I to III was used to reflect the degree of opacification. With grades II and III, posterior capsule opacification detectable with an undilated pupil was present in the central axis.
Three hundred twenty-seven (81.8%) of the selected population were examined between October 1997 and December 1998. Thirty-four (8.5%) were confirmed as being deceased, and 39 (9.8%) were unavailable for follow-up. The median age was 60 years, and 57.2% were women. The 4-year incidence of grade II or III posterior capsule opacification, including eyes already treated with laser capsulotomy, was 13.1% (95% confidence interval [CI], 9.7% to 17.3%). Each year of increased age was associated with a decreased risk of posterior capsule opacification (odds ratio, 0.96; 95% CI, 0.92 to 1.00). Based on best-corrected visual acuity of 20/40 or worse without co-existing pathology, the 4-year incidence of posterior capsule opacification was 13.5%.
Because patients with relatively mature cataracts routinely receive extracapsular cataract extraction with posterior chamber intraocular lens implantation instead of the traditional intracapsular extraction, the subsequent need for laser capsulotomy may be less than that anticipated, based on previous reports.
评估参加马杜赖人工晶状体研究并接受了囊外白内障摘除联合后房型人工晶状体植入术的患者术后4年的后囊膜混浊累积发生率。
在马杜赖人工晶状体研究中,1700例较好眼最佳矫正视力为20/120或更差的患者接受了囊外白内障摘除联合后房型人工晶状体植入术,其中1474例(86.7%)完成了1年的随访检查。从这1474例人工晶状体眼患者中,随机选取400例在初次手术后4年进行复查。由参与1年随访检查及后囊膜混浊分级的眼科医生对手术眼进行检查。采用I至III级分级来反映混浊程度。II级和III级时,在中央轴线上存在可在未散瞳情况下检测到的后囊膜混浊。
在1997年10月至1998年12月期间对327例(81.8%)入选人群进行了检查。34例(8.5%)被证实已死亡,39例(9.8%)无法进行随访。中位年龄为60岁,女性占57.2%。II级或III级后囊膜混浊的4年发生率,包括已接受激光囊膜切开术治疗的眼,为13.1%(95%置信区间[CI],9.7%至17.3%)。年龄每增加一岁,后囊膜混浊风险降低(比值比,0.96;95%CI,0.92至1.00)。基于最佳矫正视力为20/40或更差且无并存病变,后囊膜混浊的4年发生率为13.5%。
由于患有相对成熟白内障的患者常规接受囊外白内障摘除联合后房型人工晶状体植入术而非传统的囊内摘除术,基于既往报告,后续激光囊膜切开术的需求可能低于预期。